Publicaciones en las que colabora con José Angel Richter (35)

2020

  1. Incidental diagnosis of neuroendocrine tumour with 68Ga-PSMA PET/CT: Report of clinical case

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 2, pp. 102-103

2018

  1. Significant dose reduction is feasible in FDG PET/CT protocols without compromising diagnostic quality

    Physica Medica, Vol. 46, pp. 134-139

2016

  1. Index lesion characterization by 11C-Choline PET/CT and Apparent Diffusion Coefficient parameters at 3 Tesla MRI in primary prostate carcinoma

    Prostate, Vol. 76, Núm. 1, pp. 3-12

2015

  1. Radiation dosimetry and biodistribution in non-human primates of the sodium/iodide PET ligand [18F]-tetrafluoroborate

    EJNMMI Research, Vol. 5, Núm. 1, pp. 1-9

2014

  1. PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization

    Medical Physics, Vol. 41, Núm. 9

  2. Validación de técnicas de segmentación para la tomografía por emisión de positrones mediante imágenes ex-vivo de piezas quirúrgicas oncológicas

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 33, Núm. 2, pp. 79-86

  3. ¹⁸F]fluorothymidine-positron emission tomography in patients with locally advanced breast cancer under bevacizumab treatment: usefulness of different quantitative methods of tumor proliferation

    Revista española de medicina nuclear e imagen molecular, Vol. 33, Núm. 5, pp. 280-285

2013

  1. Aportación del tiempo de vuelo y de la modelización de la respuesta a una fuente puntual a las características de funcionamiento del tomógrafo PET/TAC Biograph mCT

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 32, Núm. 1, pp. 13-21

  2. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 9, pp. 1394-1405

  3. Impact of time-of-flight and point-spread-function in SUV quantification for oncological PET

    Clinical Nuclear Medicine, Vol. 38, Núm. 2, pp. 103-109

2012

  1. La tomografía por emisión de positrones

    Medicina nuclear en la práctica clínica (Aula Médica Ediciones), pp. 295-308

  2. PET tracers for clinical imaging of breast cancer

    Journal of Oncology

  3. Quantitative volumetric analysis of gliomas with sequential MRI and 11C-methionine PET assessment: Patterns of integration in therapy planning

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, Núm. 5, pp. 771-781

  4. Tomografía por emisión de positrones en tumores del sistema nervioso central

    Medicina nuclear en la práctica clínica (Aula Médica Ediciones), pp. 769-778

2011

  1. Molecular imaging techniques to study the biodistribution of orally administered 99mTc-labelled naive and ligand-tagged nanoparticles

    Molecular Imaging and Biology, Vol. 13, Núm. 6, pp. 1215-1223

  2. Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients

    Journal of Immunology, Vol. 187, Núm. 11, pp. 6130-6142

2010

  1. Dual tracer 11C-choline and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment

    Molecular Imaging and Biology, Vol. 12, Núm. 2, pp. 210-217

  2. Evaluation of spatial resolution of a PET scanner through the simulation and experimental measurement of the recovery coefficient

    Computers in Biology and Medicine, Vol. 40, Núm. 1, pp. 75-80

  3. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study

    Neurobiology of Disease, Vol. 38, Núm. 3, pp. 456-463

2009

  1. New MRI, 18F-DOPA and 11C-(+)-α-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: Advantages to improve PET quantification

    NeuroImage, Vol. 47, Núm. 2, pp. 533-539